These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2629757)
1. [Epidemiologic study of HIV serology in blood donors from 5 departments in northeastern France (1985-1989)]. Aymard JP; Janot C; Contal P; Linel C; Monange G; Streiff F Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):421-9. PubMed ID: 2629757 [TBL] [Abstract][Full Text] [Related]
2. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico. Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956 [TBL] [Abstract][Full Text] [Related]
3. [Epidemiologic study of HIV serology among blood donors in the north-eastern region of France]. Fabre G; Joussemet M; Vincent M Rev Fr Transfus Hemobiol; 1990 Jun; 33(3):223-5. PubMed ID: 2206169 [No Abstract] [Full Text] [Related]
4. [2-year anti-HIV donor screening in the Central Laboratory of the Swiss Red Cross Blood Transfusion Service]. Lang O; Bachmann P; Baumgartner C; Bütler R Schweiz Med Wochenschr; 1988 Apr; 118(15):547-53. PubMed ID: 3375791 [TBL] [Abstract][Full Text] [Related]
5. [HIV seropositivity in blood donors from 1990 to 1992: prevalence, estimation of residual risk of transfusion-related infections and epidemiology]. Couroucé AM Rev Fr Transfus Hemobiol; 1993 Jul; 36(4):327-37. PubMed ID: 8357445 [TBL] [Abstract][Full Text] [Related]
6. Methodologic approaches to surveillance of HIV infection among blood donors. Petersen LR; Dodd R; Dondero TJ Public Health Rep; 1990; 105(2):153-7. PubMed ID: 2108461 [TBL] [Abstract][Full Text] [Related]
7. [HIV seropositivity in blood donations: prevalence, residual risk and epidemiology. The "Retrovirus" Work Group of the French Society of Blood Transfusion]. Couroucé AM Transfus Clin Biol; 1995; 2(5):357-63. PubMed ID: 8581178 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus antibodies in sera of Australian blood donors: 1985-1990. Kaldor J; Whyte B; Archer G; Hay J; Keller A; Kennedy T; Mackenzie I; Pembrey R; Way B; Whyte G Med J Aust; 1991 Sep; 155(5):297-300. PubMed ID: 1895970 [TBL] [Abstract][Full Text] [Related]
10. [Four year management of HIV serology at the National Center of Blood Transfusion in Conakry]. Loua A; Magassouba FB; Camara M; Haba NG; Balde AM Bull Soc Pathol Exot; 2004 May; 97(2):139-41. PubMed ID: 15255362 [TBL] [Abstract][Full Text] [Related]
11. HIV seroprevalence in healthy blood donors in northeastern Zaire. Fischer PR; Toko RM Int J STD AIDS; 1995; 6(4):284-6. PubMed ID: 7548293 [TBL] [Abstract][Full Text] [Related]
12. HIV seroprevalence among healthy blood donors in northeastern Zaire. Fischer PR; Horton GL; Knight P; Lusi KM Int J STD AIDS; 1991; 2(1):52-3. PubMed ID: 2036462 [TBL] [Abstract][Full Text] [Related]
13. Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus: Thailand. Nuchprayoon C; Tanprasert S; Chumnijarakij T; Thanomchat S; O'Prasert B; Adulwijit S Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):98-103. PubMed ID: 8525427 [TBL] [Abstract][Full Text] [Related]
14. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand. Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence and epidemiologic features of subjects found to be infected with HIV when donating blood. CTS of the "Retrovirus" Study Group of the Société Nationale de Transfusion Sanguine]. Couroucé AM; Baudelot J; Elghouzzi MH; Gueguen M; Janot C; Lemaire JM; Maniez M; Mesnier F; Noël L; North ML Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):431-8. PubMed ID: 2285451 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety. McFarland W; Mvere D; Katzenstein D AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107 [TBL] [Abstract][Full Text] [Related]
17. Trends in human immunodeficiency virus seroprevalence in blood donors in northern Pakistan. Ghani E; Rathore MA; Khan SA Public Health; 2016 Feb; 131():71-4. PubMed ID: 26652710 [TBL] [Abstract][Full Text] [Related]
18. HIV-related risk factors of blood donors in northern Thailand before and after knowing HIV test results. Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE Int J Epidemiol; 1997 Apr; 26(2):408-13. PubMed ID: 9169178 [TBL] [Abstract][Full Text] [Related]
19. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324 [TBL] [Abstract][Full Text] [Related]
20. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience. Vučetić D; Kecman G; Ilić V; Balint B Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]